Author

Carole A. Ramm

Observed name: Carole Ramm

Institution: University of Michigan

Observed institutions: University of Michigan, Michigan Medicine

OpenAlex ID: A5023016208

The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial

2014 · Antonio M. Lerario, Francis P. Worden, et al. · Hormones and Cancer · 113

Abiraterone Acetate to Lower Androgens in Women With Classic 21-Hydroxylase Deficiency

2014 · Richard J. Auchus, Elizabeth O. Buschur, et al. · The Journal of Clinical Endocrinology & Metabolism · 98

Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency

2016 · Adina F. Turcu, Joanna L. Spencer-Segal, et al. · The Journal of Clinical Endocrinology & Metabolism · 62

Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial

2014 · Antonio M. Lerario, Francis P. Worden, et al. · Hormones and Cancer · 2

Works count: 4

Citation count: 275

H-index: 3

I10-index: 3